C12Y 504/99017
Squalene--hopene cyclase
Official title: Squalene--hopene cyclase (5.4.99.17)
C12Y504/99017 (Squalene--hopene cyclase) appears on 19 US grants and 32 published applications in this corpus.
Search patents in C12Y- Granted patents
- 19
- Published applications
- 32
- Assignees
- 9
- Inventors
- 52
- Latest grant
- 24 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2012 | 0 | 1 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 1 |
| 2016 | 1 | 2 |
| 2017 | 0 | 1 |
| 2018 | 1 | 2 |
| 2019 | 3 | 3 |
| 2020 | 3 | 3 |
| 2021 | 3 | 2 |
| 2022 | 1 | 1 |
| 2023 | 1 | 6 |
| 2024 | 2 | 3 |
| 2025 | 2 | 3 |
| 2026 | 1 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Enzyme-mediated process for making Amberketal and Amberketal homologues24 Mar 2026US 12,584,153 B2Givaudan SA
- Squalene hopene cyclase (SHC) variants16 Sep 2025US 12,416,027 B2Givaudan SA
- Method for purifying (−)-Ambrox2 Sep 2025US 12,404,531 B2Givaudan SA
- Solid form of (−)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst10 Sep 2024US 12,084,699 B2Givaudan SA
- Enzyme mediated process23 Apr 2024US 11,965,195 B2Givaudan SA
- Conversion of homofarnesol to ambroxide10 Sep 2026US 2026/0265797 A1Conagen Inc.
- Method for purifying (-)-ambrox5 Mar 2026US 2026/0062725 A1Givaudan SA
- Shc enzymes and enzyme variants12 Feb 2026US 2026/0043058 A1Givaudan SA
- Sterol production in yeast8 Jan 2026US 2026/0009064 A1Apix Biosciences
- Squalene hopene cyclase variants for producing sclareolide4 Dec 2025US 2025/0368978 A1International Flavors & Fragrances Inc.
Most cited
By later US patents
- Method for the biocatalytic cyclization of terpenes and cyclase mutants employable therein10US 8,932,839 B2BASF SE · 2015
- Method for the biocatalytic cyclization of terpenes and cyclase mutants employable therein4US 9,447,404 B2BASF SE · 2016
- Solid form of (−)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst3US 10,844,412 B2Givaudan S. A. · 2020
- Method for the biocatalytic cyclization of terpenes and cyclase mutants employable therein2US 10,190,112 B2BASF SE · 2019
- Solid form of (-)-Ambrox formed by a bioconversion of homofarnesol in the presence of a biocatalyst1US 11,773,419 B2Givaudan SA · 2023